-
Symbol
-
CVAC on Nasdaq
-
Investment type
-
Equity / Common Shares, par value (euro) 0.12 per share
-
Latest Disclosed Ownership
-
16.6M shares
-
Security Ownership
-
74%
GSK plc ownership in CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)
2025-08-13 - GSK plc has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 16.6M shares of CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC).
This represents 74% percent ownership of the company.